From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the Acute Coronary Syndromes;De la placa vulnerable solitaria, a la coronariopatía de múltiples vasos. De sus fundamentos, a las implicaciones terapéuticas modernas. Una realidad clínica en el espectro de los SICA

Archivos de Cardiologia de Mexico

Volumn 76, Issue SUPPL. 1, 2006, Pages

  Herrera, Eulo Lupi ^c   Valenzuela, Eduardo Chuquiure ^a   Gaspar, Jorge ^b   Santander, Sergio Mario Férez ^d  

^a Departamento de Urgencias y Unidad Coronaria   (Mexico)

^b Departamento de Hemodinámica   (Mexico)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d NONE

Author keywords

Acute coronary syndromes; Inflammation; Multiplicity of coronary vulnerable plaques

Indexed keywords

C REACTIVE PROTEIN; FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; AUTOPSY; CHLAMYDOPHILA PNEUMONIAE; DISEASE COURSE; ECHOCARDIOGRAPHY; FIBRINOLYSIS; HUMAN; LABORATORY TEST; NONHUMAN; PATHOGENESIS; PROGNOSIS; REVIEW;

EID: 34047197745     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (218)

1. BRAUNWALD E, ANTMAN EM, BEASLEY JW, CALIFF RM, CHEITLIN MD, HOCHMAN JS, ET AL: ACC/AHA guidelines for the managements of patients with unstable angina and non-ST segment elevation MI: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [Committee on Management of Patients With Unstable Angina]. J Am Coll Cardiol 2000; 36:970-1062.
2. KOHCHI R, TAKEBAYASHI S, HIROKI T, NOBUYOSHI M: Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985; 71: 709-716.
3. WALLSH E, WEINSTEIN GS, FRANZONE A, CLAVEL A, ROSSI PA, KREPS E: Inflammation of the coronary arteries in patients with unstable angina. Tex Heart Inst J 1986: 105-113.
4. SATO T: Increased subendothelial infiltration of the coronary arteries with monocytes -macrophages in patients with unstable angina. Atherosclerosis 1987; 68: 191-197.
5. BAROLDI G, SILVER MD, MARIANI F, GIULIANO G: Correlation of morphological variable in the coronary atherosclerotic plaque with clinical patterns of ischemic heart disease. Am J Cardiovasc Pathol 1988; 2: 159-172.
6. VAN DER WAL AC, BECKER AE, VAN DER LOOS CM, DAS PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of dominant plaque morphology. Circulation 1994; 89: 36-44.
7. MORENO PR, FALK E, PALACIOS IF, NEWELL JB, FUSTER V, FALLON JT: Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994; 90: 775-778.
8. BIASUCCI LM, D'ONOFRIO G, LIUZZO G, ZINI G, MONACO C, CALGIURI G, ET AL: Intracellular neutrophil myeloperoxidase is reduced in unstable angina and myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996; 27: 611-616.
9. METHA JL, DINERMAN J, METHA P, SALDEEN TGP, LAWSON D, DONNELLY WH, WALLIN R: Neutrophil function in ischemic heart disease. Circulation 1989; 79: 549-556.
10. DINERMAN JL, METHA JL, SALDEEN TG, EMERSON S, WALLIN R, DAVDA R, DAVIDSON A: Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990; 15: 1559-1563.
11. NERI SERNERI GG, ABBATE R, GORI AM, ATTANASIO M, MARTINI F, GIUSTI D, ET AL: Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-797.
12. MAZZONE A, DE SERVI S, RICEVUTI G, MAZZUCCHELLI I, FOSSATI G, PASSOTTI D, ET AL: Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
13. JUDE B, AGRAOU B, MCFADDEN EP, SUSEN S, BAUTERS C, LEPELLEY P, ET AL: Evidence for time- dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or stable angina. Circulation 1994; 90: 1662-1668.
14. BERK BC, WEINTRAUB WS, ALEXANDER RW: Elevation of C-reactiveprotein in "active" coronary artery disease. Am J Cardiol 1990; 65: 168-172.
15. JUHAN-VAGUE I, ALESSI MC, JOLY P, THIRION X, VAGUE P, DECLERK PJ, SERRADIMIGNI A, COLLEN D: Plasma plasminogen activator inhibitor-1 in angina pectoris; influence of plasma insulin and acute-phase response.
16. LIUZZO G, BIASUCCI LM, GALLIMORE JR, GRILLO RL, REBUZZI AG, PEPYS MB, ET AL: Prognostic value of C- reactive protein and plasma amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
17. ENGLER R, COVELL JW: Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 1987; 61: 20-28.
18. GO LO, MURRY CE, RICHARD VJ, WEISCHEDEL GR, JENNINGS RB, REIMER KA: Myocardial neutrophil accumulation during reperfusion after irreversible ischemic injury. Am J Physiol 1988; 255: H1188-H1198.
19. ENGLER RL: Free radical and granulocyte mediated injury during myocardial ischemia and reperfusion. Am J Cardiol 1989; 63: 19E-23E.
20. ENTMAN ML, MICHAEL L, ROSSEN RD, DREYER WJ, ANDERSON DC, TAYLOR AA, SMITH CW: Inflammation in the course of early myocardial ischemia. FASEB J 1991; 5: 2529-2537.
21. DREYER WJ, MICHAEL LH, NGUYEN T, SMITH CW, ANDERSON DC, ENTMAN ML, ROSSEN RD: Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ Res 1992; 71: 1518-1524.
22. GHEZZI P, DINARELLO CA, BIANCHI M, ROSANDICH ME, REPINE JE, WHITE CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor and human mononuclear cells. Cytokine 1991; 3: 189-194.
23. KUKIELKA GL, YOUKER KA, HAWKINS HK, PERRARD JL, MICHAEL LH, BALLANTYNE CM, ET AL: Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann N Y Acad Sci 1994; 723: 258-270.
24. TAKIHARA KY, IHARA Y, OGATA A, YOSHIZAKI K, AZUMA J, KISHIMOTO T: Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 1995; 91: 1520-1524.
25. LUPI HE, LASSES LA, COSIO AJ, CHUQUIURE EV, MARTÍNEZ SC, ORTÍZ P, ET AL: Acute right ventricular infarction: clinical spectrum, results of reperfusion therapy and short-term prognosis. Coron Artery Dis 2002; 13: 57-64.
26. FUSTER V, BADIMON L, BADIMON JJ, CHESEBRO JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250.
27. FUSTER V, BADIMON L, BADIMON JJ, CHESEBRO JH: Pathogenesis of coronary artery disease and the acute coronary syndromes [part II]. N Engl J Med 1992; 326: 310-318.
28. AMBROSE J, TANNENBAUM M, ALEXOPOULOS D, HJEMDAHL-MONSEN CE, LEAVY J, WEISS M, ET AL: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12: 56-62.
29. FALK E: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusion thrombi. Br Heart J 1983; 50: 127-34.
30. AMBROSE JA, WINTERS SL, STERN A, ENG A, TEICHHOLZ LE, GORLIN R, FUSTER V: Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-616.
31. FUSTER V: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994; 90: 2126-2146.
32. DAVIES MJ, THOMAS AC: Plaque fissuring: the cause of acute myocardial infarction, sudden death, and crescendo angina. Br Heart J 1985; 53: 363-373.
33. WILCOX JN, SMITH KM, SCHWARTZ SM, GORDON D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
34. WILCOX JN: Thrombotic mechanisms in atherosclerosis. Coron Artery Dis 1994; 5: 223-229.
35. FUSTER V, BADIMON L, COHEN M, AMBROSE JA, BADIMON JJ, CHESEBRO J: Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213-1220.
36. AMBROSE JA, HJEMDAHL-MOSEN CE: Arteriographic anatomy and mechanisms of ischemia in unstable angina. J Am Coll Cardiol 1987; 9: 1397-1402.
37. FALK E, SHAH PK, FUSTER V: Coronary plaque disruption. Circulation 1995; 92: 657-671.
38. BURKE AP, KOLODGIE FD, FARB A, WEBER A, MALCOM GT, SMIALEK J, VIRAMANI R: Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 2001; 103: 934-940.
39. VIRMANI R, BURKE AP, FARB A: Plaque rupture and plaque erosion. Thromb Haemost 1999; 82 [Suppl2]: 1-3.
40. FARB A, BURKE AP, TANG AL, LIANG Y, ET AL: Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354-1363.
41. RICHARDSON RD, DAVIES MJ, BORN GVR: Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; 2: 941-944.
42. DAVIES MJ, RICHARDSON PD, WOOLF N, KATZ DR, MANN J: Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophages, and smooth muscle cell content. Br Heart J 1993; 69: 377-381.
43. SERNERI GGN, GENSINI GF, POGGESI L, MODESTI PA, ROSTAGNO C, BODDI M, ET AL: The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes. Coron Artery Dis 1994; 5: 137-145.
44. LIBBY P: Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
45. LOREE HM, KAMM RD, STRINGFELLOW RG, LEE RT: Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992; 71: 850-858.
46. CHENG GC, LOREE HM, KAMM RD, FISHBEIN MC, LEE RT: Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathologic correlation. Circulation 1993; 87: 1179-1187.
47. LEE RT, GRODZINSKY AJ, FRANK EH, KAMM RD, SCHOEN FJ: Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation 1991; 83: 1764-1770.
48. LEUNG DYM, GLAGOV S, MATHEWS MB: Cyclic stretching stimulates synthesis of matrix components by arterial smooth muscle cells in vitro. Science 1976; 191: 475-477.
49. BARGER AC, BEEUWKES R III: Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. Am J Cardiol 1990; 66: 41G-43G.
50. MASERI A, L'ABBATE A, BAROLDI G: Coronary vasospasm as possible cause of myocardial infarction: a conclusion derived from the study of "preinfarction angina". N Engl J Med 1978; 299: 1271-1277.
51. LIBBY P, RIDKER PM, MASERI A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
52. SHAH PK: Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Progress Cardiovasc Dis 2002; 44: 357-368.
53. GALIS ZS, MUSZYNSKI M, SUKHOVA GK, SIMON-MORRISEY E, LIBBY P: Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann NY Acad Sci 1995; 748: 501-507.
54. BJORKERUD S, BJORKERUD B: Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells [macrophages and T cells] and may contribute to accumulation of gruel and plaque instability. Am J Pathol 1994; 149: 367-380.
55. GOLDSTEIN JA, DEMETRIOU D, GRINES CL, PICA M, SHOUKFEH M, O'NEIL W: Multiple complex coronary plaques inpatients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922.
56. FALK E: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-134.
57. QIAO JH, FISHBEIN MC: The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis. J Am Coll Cardiol 1991; 17: 1138-1142.
58. CHAPMAN I: Morphogenesis of occluding coronary artery thrombosis._Arch Pathol 1965; 80: 256-261.
59. ROBERTS WC, BUJA LM: The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction: a study of 107 necropsy patients. Am J Med 1972; 52: 425-443.
60. FRINK RJ: Chronic ulcerated plaques: new insights into the pathogenesis of acute coronary disease. J Invasive Cardiol 1994; 6: 173-185.
61. GUAZZI MD, BUSSOTTI M, GRANCINI L, DE CESARE N, GUAZZI M, PERA LI, LOALDI A: Evidence of multifocal activity of coronary disease in patients with acute myocardial infarction. Circulation 1997; 96: 1145-1151.
62. BODEN WE, KERENSKY RA, BERTOLET BD, DEEDWANIA P, CHOW BK, PEPINE CJ: Coronary angiographic findings after non-Q-wave myocardial infarction: an analysis from the VANQUISH trial. Eur Heart J 1997; 18 [Suppl 1]: 123 A.
63. AMBROSE JA: Prognostic implications of lesion irregularity on coronary angiography. J Am Coll Cardiol 1991; 18: 675-676.
64. THEROUX P: Angiographic and clinical progression in unstable angina: from clinical observations to clinical trials. Circulation 1995; 91: 2295-2298.
65. DAVIES SW, MARCHANT B, LYONS JP, TIMMIS AD: Irregular coronary lesion morphology after thrombolysis predicts early clinical instability. J Am Coll Cardiol 1991; 18: 669-674.
66. MOISE A, THEROUX P, TAEYMANS Y, DESCOINGS B, LESPERANCE J, WATERS DD, ET AL: Unstable angina and progression of coronary atherosclerosis. N Engl J Med 1983; 309: 685-689.
67. CHEN L, CHESTER MR, REDWOOD S, HUANG J, LEATHAM E, KASKI JC: Angiographic stenosis progression and coronary events in patients with stabilized unstable angina. Circulation 1995; 91: 2319-2324.
68. CHESTER MR, CHEN L, KASKI JC: The natural history of unheralded complex coronary plaques. J Am Coll Cardiol 1996; 28: 604-608.
69. CHEN L, CHESTER MR, CROOK R, KASKI JC: Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris. J Am Coll Cardiol 1996; 28: 597-603.
70. KASKI JC, CHESTER MR, CHEN L, KATRITSIS D: Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 1995; 92: 2058-2065.
71. FREEMAN MR, WILLIAMS AE, CHISHOLM RJ, ARMSTRONG PW: Intracoronary thrombus and complex morphology in unstable angina: relation to timing of angiography and in-hospital cardiac events. Circulation 1989; 80: 17-23.
72. KULLER LH, TRACY RP, SHATEN J, MEILAHN EN: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemol 1996; 144: 537-547.
73. KOENIG W, SUND M, FROHLICH M, FISCHER HG, LOWEL H, DORING A, ET AL: C-reactive protein a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA [Monitoring Trends and Determinants in Cardiovascular Disease] Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
74. DANESH J, WHINCUP P, WALKER M, LENNON L, THOMSON A, APPLEBY P, GALLIMORE JR, PEPYS MB: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.
75. RIDKER PM, STAMPFER MJ, RIFAI N: Novel risk factors for systemic arthrosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein [a] and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485.
76. MULLANE KM, READ N, SALMON JA, MONCADA S: Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage bi anti-inflammatory drugs. J Pharmacol Exp Ther 1983; 228: 510-522.
77. BIASUCCI LM, LIUZZO G, GRILLO RL, CALIGIURI G, REBUZZI AG, BUFFON A, ET AL: Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99: 855-860.
78. LINDAHL B, TOSS H, SIEGBAHN A, VENGE P, WALLENTIN L: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139-1147.
79. HEESCHEN C, HAMM CW, BRUEMMER J, SIMOONS ML: Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 Antiplatelet Therapy in Unstable angina Refractory to standard treatment trial. J Am Coll Cardiol 2000; 35: 1535-1542.
80. LIUZZO G, BIASUCCI LM, REBUZZI AG, GALLIMORE JR, CALIGIURI G, LANZA GA, ET AL: Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation 1996; 94: 2373-2380.
81. YUDKIN JS, STEHOUWER CD, EMEISS JJ, COPPACK SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 972: 972-978.
82. FORD ES: Body mass index, diabetes and C-reactive protein among US adults. Diabetes Care 1999; 22: 1971-1977.
83. KENNON S, PRICE CP, MILLS PG, RANJADAYALAN K, PHIL M, COOPER J, ET AL: The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol 2001; 37: 1266-1270.
84. FELDMAN M, JIALAL I, DEVARAJ S, CRYER B: Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo - controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol 2001; 37: 2036-2041.
85. IKONOMIDIS I, ANDREOTTI F, ECONOMOU E, STEFANADIS C, TOUTOUZAS P, NIHOYANNOPOULOS P: Increased proinflammatory cytokines in patients with chronic stable angina and their reductions by aspirin. Circulation 1999; 100: 793-798.
86. FUKUMOTO Y, LIBBY P, RABKIN E, HILL CC, ENOMOTO M, HIROUCHI HILL CC, ENOMOTO M, HIROUCHI, ET AL: Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 2001; 103: 993-999.
87. SHAH PK, KAUL S, NILSSON J, CERCEK B: Exploiting the vascular protective effects of HDL and its apoliproteins: an idea whose time for testing is coming, Part II. Circulation 2001; 104: 2498-2502.
88. CLAUDEL T, LEIBOWITZ MD, FIEVET C, TAILLEUX A, WAGNER B, REPA JJ, ET AL: Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci USA 2001; 98: 2610-2615.
89. AIKAWA M, RABKIN E, OKADA Y, VOGLIC SJ, CLINTON SK, BRINCKERHOFF CE, ET AL: Lipid lowering by diet reduces matrix metalloproteinases activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998; 97: 2433-2444.
90. IKEDA U, SHIMPO M, OHKI R, INABA H, TAKAHASHI M, YAMAMOTO K, SHIMADA K: Fluvastatin inhibits matrix metalloproteinases -1 expression in human vascular endothelial cells. Hypertension 2000; 36: 325-329.
91. GARCÍA-MOLL X, COCCOLO F, COLE D, KASKI JC: Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000; 35: 956-962.
92. WILLIAMS JK ,SUKHOVA GK, HERRINGTON DM, LIBBY P: Pravastatin has cholesterol -lowering independent effects on the artery wall of atherosclerotic-monkeys. J Am Coll Cardiol 1998; 31: 684-691.
93. CRISBY M, NORDIN-FREDRIKSSON G, SHAH PK, YANO J, ZHU J, NILSON J: Pravastatin treatment increases collagen content and decrease lipid content, inflammation, metalloproteinases and cell death in human carotid plaques: implications for plaque stabilization. Circulation 2001; 103: 926-933.
94. NIWA S, TOTSUKA T, HAYASHI S: Inhibitory effect of fluvastatin an HMG-CoA reductase inhibitor on the expression of adhesion molecules on human monocyte cell line. Int J Immunopharmacol 1996; 18: 669-675.
95. IKEDA U, SHIMADA K: Statins and monocytes. Lancet 1999; 353: 2070.
96. ROSENSON RS, TANGNEY CC, CASEY LC: Inhibition of proinflammatory cytokine production by pravastatin. Lancet 1999; 353: 983-984.
97. FERRO D, PARROTTO S, BASILI S, ALESSANDRI C, VIOLI F: Simvastatin inhibits the monocyte expression of proinflammatory cytokines inpatients with hypercholesterolemia. J Am Coll Cardiol 2000; 36: 427-431.
98. BUSTOS C, HERNANDEZ-PRESA MA, ORTEGO M, TUÑON J, ORTEGA L, PÉREZ F, ET AL: HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998; 32: 2057-2064.
99. ASAKURA M, UEDA Y, YAMAGUCHI O, ADACHI T, HIRAYAMA A, HORI M, KODAMA K: Extensive development of vulnerable plaques as an a pancoronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288.
100. SHERMAN CT, LITVACK F, GRUNDFEST W, LEE M, HICKEY A, ET AL: Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 1986; 315: 913-919.
101. MIZUNO K, MIYAMOTO A, SATOMURA K, KURITA A, ARAI T, ET AL: Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet 1991; 337: 809-812.
102. UEDA Y, ASAKURA M, HIRAYAMA A, KOMAMURA K, HORI M, KODAMA K: Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction. J Am Coll Cardiol 1996; 27: 606-610.
103. SIEGEL RJ, ARIANI M, FISHBEIN MC, CHAE JS, PARK JC, FORRESTER JS: Histopathologic validation of angioscopy and intravascular ultrasound. Circulation 1991; 84: 109-117.
104. THIEME T, WERNECKE KD, MEYER R, BRANDENSTEIN E, HABEDANK D, FELIX SB, ET AL: Angioscopic evaluation of atherosclerotic plaques: validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 1996; 28: 1-6.
105. Scandinavian Simvastatin Survival Group. Randomized trial of cholesterol lowering in 4, 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study [4 S]. Lancet 1994; 344: 1383-1389.
106. BEMIS CE, GORLIN R, KEMP HG, HERMAN MV: Progression of coronary artery disease: a clinical arteriographic study. Circulation 1973; 47: 455-464.
107. KRAMER JR, MATSUDA Y, MULLIGAN JC, ARONOW M, PROUDFIT WL: Progression of coronary atherosclerosis. Circulation 1981; 63: 519-526.
108. CLARKSON TB, PRICHARD RW, MORGAN TM, PETRICK GS, POTVIN KLEIN K: Remodeling of coronary arteries in human and nonhuman primates. JAMA 1994; 271: 289-294.
109. VAN BELLE E, LABLANCHE JM, BAUTERS C, RENAUD N, MCFADDEN EP, BERTRAND ME: Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction: natural history an the effect of thrombolysis. Circulation 1998; 97: 26-33.
110. TABATA H, MIZUNO K, ARAKAWA K, SATOMURA K, SHIBUYA A, NAKAMURA H: Angioscopic identification of coronary thrombus inpatients with postinfarction angina. J Am Coll Cardiol 1995; 25: 1282-1285.
111. DEN HEUER P, FOLEY DP, ESCANED J, HILLEGE HL, VAN DIJK RB, SERRUYS PW, LIE KI: Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll Cardiol 1994; 24: 649-654.
112. WHITE CJ, RAMEE SR, COLLINS TJ, ESCOBAR AE, KARSAN A, SHAW D, ET AL: Coronary thrombus increase PTCA risk: angioscopy as a clinical tool. Circulation 1996; 93: 253-258.
113. VON BIRGELEN C, KILNKHART W, MINTZ G, PAPATHEODOROU A, HERRMANN J, BRAUMGART D, ET AL: Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 2001; 37: 1864-1870.
114. TAKANO M, MIZUNO K, OKAMATSU K, YOKOYAMA S, OHBA T, SAKAI S: Mechanical and structural characteristics of vulnerable plaques: analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 2001; 38: 99-104.
115. MAZZONE A, DE SERVI S, RICEVUTTI G, MAZZUCCHELLI I, FOSSATI G, PASOTTI E, ET AL: Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
116. DE SERVI S, MAZZONE A, RICEVUTTI G, MAZZUCHELLI I, FOSSATI G, ANGOLI L, ET AL: Expression of neutrophil and monocyte CD11B/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris. Am J Cardiol 1996; 78: 564-568.
117. HAZEN SL, D'AVIGNON A, ANDERSON MM, HSU FF, HEINECKE JW: Human neutrophils employ the myeloperoxidase-hydrogen peroxide -chloride system to oxidize alpha-amino acids to a family of reactive aldehydes: mechanistic studies identifying along the reaction pathway. J Biol Chem 1998; 273: 4997-5005.
118. BUFFON A, BIASUCCI LM, LIUZZO G, D'ONOFRIO G, CREA F, MASERI A: Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12.
119. JORDAN JE, ZHAO ZQ, VINTEN-JOHANSEN J: The role of neutrophils in myocardial ischemia -reperfusion injury._Cardiovasc Res 1999; 43: 860-878.
120. DI SCIASCIO G, COWLEY MJ, GOUDREAU E, VETROVEC GW, JOHNSON DE: Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: in vivo evidence of thrombosis, ulceration and inflammation. Am Heart J 1994; 128: 419-426.
121. DAVIES MJ: A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990; 82 [Suppl II]: II-38-II-46.
122. ARBUSTINI E, GRASSO M, DIEGOLI M, PUCCI A, BRAMERIO M, ARDISSINO D, ET AL: Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical and biochemical study. Am J Cardiol 1991; 68 [Suppl]: 36B-50B.
123. UREN NG, CRAKE T, LEFROY DC, DE SILVA R, DAVES GJ, MASERI A: Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994; 331: 222-227.
124. GIBSON CM, RYAN KA, MURPHY SA, MESLEY R, MARBLE SJ, GIUGLIANO RP, ET AL: Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. J Am Coll Cardiol 1999; 34: 974-982.
125. ARAUJO LI, CAMICI P, SPINKS TJ, JONES T, MASERI A: Abnormalities in myocardial metabolism in patients with unstable angina as assessed by positron emission tomography. Cardiovasc Drugs Ther 1988; 2: 41-46.
126. WALLSH E, WEINSTEIN GS, FRANZONE A, CLAVEL A, ROSSI PA, KREPS E: Inflammation of the coronary arteries in patients with unstable angina. Tex Heart Inst J 1986; 13: 105-108.
127. BIASUCCI LM, LIUZZO G, FANTUZZI G, CALIGIURI G, REBUZZI AG, GINNETTI F, ET AL: Increasing levels of interleukin [IL] -1 Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of inhospital coronary events. Circulation 1999; 99: 2079-2084.
128. BIASUCCI LM, VITELLI A, LIUZZO G, ALTAMURA S, CALIGIURI G, MONACO C, ET AL: Elevated levels of interleukin -6 in unstable angina. Circulation 1996; 94: 874-877.
129. LIUZZO G. BIASUCCI LM, GALLIMORE JR, CALIGIURI C, BUFFOON A, REBUZZI AG, ET AL: Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 1999; 34: 1696-1703.
130. SPAGNOLI LG, BONANNO E, MAURIELLO A, PALMIERI G, PARTENZI A, SANGIOGI G, CREA F: Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002; 40: 1579-1588.
131. LIBBY P: Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000; 86: 3J-8J.
132. BONANNO E, MAURIELLO A, PARTENZI A, ANEMONA L, SPAGNOLI LG: Flow cytometry analysis of atherosclerotic plaque cells from human carotids: a validation study. Cytometry 2000; 39: 158-165.
133. NERI SERNERI GG, PRISCO D, MARTINI F, GORI AM, BRUNELLI T, ET AL: Acute T-cell activation is detectable in unstable angina. Circulation 1997; 95: 1806-1812.
134. CALIGIURI C, PAULSSON G, NICOLETTI A, MASERI A, HANNSON GK: Evidence of antigen-driven T-cell response in unstable angina. Circulation 2000; 102: 1114-1119.
135. HANSSON G, HOLM J, JONASSON L: Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175.
136. CREA F, BIASUCCI LM, BUFFON A, LIUZZO G, MONACO C, CALIGIURI G, ET AL: Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol 1997; 80: 10E-16E.
137. LIUZZO G, GORONZY JJ, YANG H, KOPECKY SL, HOLMES DR, FRYE RL, WEYAND CM: Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101: 2883-2888.
138. GILPIN EA, KOZIOL JA, MADSEN EB, HENNING H, ROSS J: Periods of differing mortality distribution during the first year after acute myocardial. Am J Cardiol 1983; 52: 240-244.
139. ISNER JM, KEARNEY M, BORTMAN S, PASSERI J: Apoptosis in human atherosclerosis and restenosis._Circulation 1995; 91: 2703-2711.
140. KNOCKX MM: Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. ArteriosclerThromb Vasc Biol 1998; 18: 1519-1522.
141. HAN DK, HAUDENSCHILD CC, HONG MK, TINKLE BT, LEON MB, LIAU G: Evidence of apoptosis in human atherogenesis and in rat vascular injury model. Am J Pathol 1995; 147: 267-277.
142. BOMBELI T, KARSAN A, TAIT JF, HARLAN JM: Apoptotic vascular endothelial cells become procoagulant._Blood 1997; 89: 2429-2442.
143. BOMBELI T, SCHWARTZ BR, HARLAN JM: Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood 1999; 93: 3831-3838.
144. VALGIMIGLI M, AGNOLETTI L, CURELLO S, COMINI L, FRANCOLINI G, MASTRORILLI F, ET AL: Serum from patients with acute coronary syndromes displays a proapoptotic effect on human endothelial cells. A possible link to pan-coronary syndromes. Circulation 2003; 107: 264-270.
145. AZAR RR, RINFRET S, THEROUX P, STONE PH, DAKSHINAMURTHY R, FENG YJ, ET AL: A randomized placebo-controlled trial to assess the efficacy of anti-inflammatory therapy with Methylprednisolone in Unstable Angina [MUNA trial]. Eur Heart J 2000; 21: 2026-2032.
146. FUSTER V, CORTI R, BADIMON JJ: Therapeutic targets for the treatment of atherothrombosis in the new millennium: Clinical frontiers in atherosclerosis research. Circulation 2002; 66: 783-790.
147. MAURIELLO A, SANGIORGI G, FRATONI S, PALMIERI G, BONANNO E, ANEMONA L, ET AL: Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree. A histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005; 45: 1585-1593.
148. TANAKA A, SHIMADA K, SANO T, NAMBA M, SAKAMOTO T, NISHIDA Y, ET AL: Multiple plaque rupture and C - reactive protein in acute myocardial infarction. J Am Coll Cardiol 2005; 45: 1594-1599.
149. RIOUFOL G, FINET G, GINON I, FOUËT A, VIALLE E, DESJOYAUX E, ET AL: Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three -vessel intravascular ultrasound study ._Circulation 2002; 106: 804-808.
150. KOTANI J, MINTZ GS, CASTAGNA MT, PINNOW E, BERZINGI CO, BIU AB, ET AL: Intravascular ultrasound analysis of infarct - related and non -related arteries in patients who presented with an acute myocardial infarction. Circulation 2003; 107: 2889-2893.
151. SCHOENHAGEN P, STONE GW, NISSEN SE, GRINES CL, GRIFFIN J, CLEMSON BS, ET AL: Coronary plaque morphology and frequency of ulceration distant from culprit lesions in patients with unstable and stable presentation. Arterioscler Thromb Vasc Biol 2003; 23: 1895-1900.
152. BERENSON GS, SRINIVASAN SR, BAO W, NEWMAN WP, TRACY RE, WATTIGNEY WA: Association between multiple cardiovascular risk factors and Atherosclerosis in children and young adults: the Bogalusa Heat Study. N Engl J Med 1998; 338: 1650-1658.
153. SANO T, TANAKA A, NAMBA M, NISHIHARU Y, NISHIDA Y, KAWARABAYASHI T, ET AL: C - reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 2003; 108: 282-285.
154. HONG MK, MINTZ GS, LEE CW, KIM YH, LEE SW, SONG JM, ET AL: Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three -vessel intravascular ultrasound study in 235 patients. Circulation 2004; 110: 928-933.
155. RIDKER PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
156. BURKE AP, TRACY RP, KOLODGIE F, MALCOM GT, ZIESKE A, KUTYS R, ET AL: Elevated C-reactive protein values and Atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105: 2019-2023.
157. ZAIRIS MN, PAPADEKI OA, MANOUSAKIS SJ, THOMA MA, BELDEKOS DJ, OLYMPIOS CD, ET AL: C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 2002; 164: 355-359.
158. PASCERI V, WILLERSON JT, YEH ET: Direct proinflammatory effect of C- reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
159. TORZEWSKI M, RIST C, MORTENSEN RF, ZWAKA TP, BIENEK M, WALTENBERG J, ET AL: C-reactive protein in the arterial intima: a role of C-reactive protein receptor -dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 2094-2099.
160. DANENBERG HD, SZALAI AJ, SWAMINATHAN RV, PENG L, CHEN Z, SEIFERT P, ET AL:
161. COLE CW, HAGEN PO, LUCAS JF, MIKAT EM, O'MALLEY KM, RADIC ZS, ET AL: Association of polymorphonuclear leucocytes with sites of aortic catheter-induced injury in rabbits. Atherosclerosis 1987; 67: 229-236.
162. DE SERVI S, MAZZONE A, RICEVUTI G, FIORAVANTI A, ANGOLI L, STEFANO G, SPECCHIA G: Granulocyte activation after coronary angioplasty in humans.
163. GOTTSAUNER-WOLF M, ZASMETA G, HORNYKEWYCZ S, NIKFARDJAM M, STEPAN E, WEXBERG P, ET AL: Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21: 1152-1158.
164. GASPARDONE A, TOMAI F, VERSACI F, GHINI AS, POLISCA P, CREA F, ET AL: Coronary artery stent placement in patients with variant angina refractory to medical treatment. Am J Cardiol 1999; 84: 96-98.
165. VERSACI F, GASPARDONE A, TOMAI F, RIBICHINI F, RUSSO P, PROIETTI I, ET AL: Immunosuppressive therapy for the prevention of restenosis after coronary stent implantation [IMPRESS Study]. J Am Coll Cardiol 2002; 40: 1935-1942.
166. INOUE T, SAKI Y, MOROOKA S, HAYASHI T, TAKAYANAGI K, TAKABATAKE Y: Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996; 28: 1127-1133.
167. INOUE T, SAKAI Y, FUJITO T, HOSHI K, HAYASHI T, TAKAYANAGI K, MOROOKA S: Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 1998; 79: 54-58.
168. INOUE T, SOHMA R, MIYAZAKI T, IWASAKI Y, YAGUSHI I, MOROOKA S: Activation process of platelets and neutrophils after coronary stent implantation: comparison with balloon angioplasty. Am J Cardiol 2000; 86: 1057-1062.
169. INOUE T, UCHIDA T, YAGUCHI I, SAKAI Y, TAKAYANAGI K, MOROOKA S: Stent - induced expression and activation of the leukocyte integrin Mac - 1 is associated with neointimal thickening and restenosis. Circulation 2003; 107: 1757-1763.
170. CASTEL JV, GÓMEZ-LECHÓN MJ, FABRA R, TRULLENQUE R, HEINRICH PC: Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin - 6. Hepatology 1990; 12: 1179-1186.
171. ISHIKAWA T, HATAKEYAMA K, IMAMURA T, DATE H, SHIBATA Y, HIKICHI Y, ET AL: Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 2003; 91: 287-292.
172. YASOJIMA K, SCHWAB C, MCGEER DE, MCGEER PL: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158: 1039-1051.
173. ISHIKAWA T, IMAMURA T, HATAKEYAMA T, DATE H, NAGOSY T, KAWAMOTO R, ET AL: Production of C - reactive protein in the coronary plaque and release into coronary circulation. Circulation 2000; 106(Suppl II): II-346.
174. INOUE T, KATO T, UCHIDA T, SAKUMA M, NAKAJIMA A, SHIBAZAKI M, ET AL: Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardiol 2005; 46: 239-245.
175. CALABRO P, WILLERSON JT, YEH ET: Inflammatory cytokines stimulated C- reactive protein production by human coronary artery smooth muscle cells. Circulation 2003; 108: 1930-1932.
176. PEPYS MB, BALTZ ML: Acute phase proteins with special reference to C-Reactive protein and related proteins [pentaxins] and plasma amyloid A protein. Adv Immunol 1983; 34: 141-212.
177. VIGUSHIN DM, PEPYS MB, HAWKINS PN: Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993; 91: 1351-1357.
178. CARRY M, KORLEY V, WILLERSON JT, WEIGELT L, FORD-HUTCHINSON AW, TAGARI F: Increased urinary leukotriene excretion in patients with cardiac ischemia: in vivo evidence for 5 -lipoxygenase activation. Circulation 1992; 85: 230-236.
179. IKEDA H, TAKAJO Y, ICHIKI K, UENO T, MAKI S, NODA T, SUGI K, IMAIZUMI T: Increased soluble form of P-selectin in patients with unstable angina._Circulation 1995; 92: 1693-1696.
180. KAIKITA K, OGAWA H, YASUE H, SAKAMOTO T, SUEFUJI H, SUMIDA H, OKUMURA K: Soluble P-selectin is released into the coronary circulation after coronary spasm. Circulation 1995; 92: 1726-1730.
181. BAYES-GENIS A, CONOVER CA, OVERGAARD MT, BAILEY KR, CHRISTIANSEN M, HOLMES DR, ET AL: Pregnancy - associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022-1029.
182. OXVIG C, SAND O, KRSITENSEN T, KRSITENSEN L, SOTTRUP- JENSEN L: Isolation and characterization of circulating complex between human pregnancy -associated plasma protein -A and proform of eosinophil major basic protein. Biochim Biophys Acta 1994; 1201: 415-423.
183. LAWRENCE JB, OXVIG C, OVERGAARD MT, SOTTRUP-JENSEN L, GLEICH ET AL: The insulin-like growth factor [IGF]-dependent IGF binding protein - 4 protease secreted by human fibroblast is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999; 96: 3149-3153.
184. XU J, DELAFONTAINE P: Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin -like growth factor -I receptor cDNA. Circ Res 1995; 76: 963-972.
185. XU Q, KIECHL S, MAYR M, METZLER B, EGGER G, OBERHOLLENZER F, ET AL: Association of serum antibodies to heat-shock protein 65 with carotid Atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999; 100: 1169-1174.
186. XU Q, SCHETT G, PERSCHINKA H, MAYR M, EGGER G, OBERHOLLENZER F, ET AL: Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000; 102: 14-20.
187. ZHU J, QUYYUMI AA, ROTT D, CSAKO G, WU H, HALCOUX J, EPSTEIN SE: Antibodies to human heatshock protein 60 are associated with the presence and severity of coronary heart disease. Circulation 2001; 103: 1071-1075.
188. HUITTINEM T, LEINONEN M, TENKANEN L, MANTTARI M, VIRKKUNEN H, PITKANEN T, ET AL: Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in preceding coronary risk. Arterioscler Thromb Vasc Biol 2002; 22: 431-437.
189. BURIAN K, KIS Z, VIROK D, ENDRESZ V, PROHASKA Z, DUBA J, ET AL: Independent and joint effects of antibodies to human heat-shock protein and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 2001; 103: 1503-1508.
190. MAYR M, MELTZER B, KIECHLS, WILLEIT J, SCHETT G, XU Q, WICK G: Endothelial cytotoxicity mediated by serum antibodies to heat -shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infections and atherosclerosis. Circulation 1999; 99: 1560-1566.
191. KOL A, BOURCIER T, LICHTMAN AH, LIBBY P: Chlamydial and human heat shock protein 60 activate human vascular endothelium, smooth muscle cells and macrophages. J Clin Invest 1999; 103: 571-577.
192. CIERVO A, VISCA P, PETRUCCA A, BIASUCCI LM, MASERI A, CASSONE A: Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin Diagn Lab Immunol 2002; 9: 66-74.
193. BIASUCCI LM, LIUZZO G, CIERVO A, PETRUCCA A, PIRO M, DOMINICK J, ET AL: Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003; 107: 3015-3017.
194. WANG JC, NORMAND SLT, MAURI L, KUNTZ RE: Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004; 110: 278-284.
195. NAGHAVI M, LIBBY P, FALK E, CASSCELLS SW, LITOVSKY S, RUMBERG J, ET AL: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-1672.
196. BURKE AP, KOLODGIE FD, FARB A, WEBER DK, MALCOM GT, SMIALEK J, VIRMANI R: Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in the plaque progression. Circulation 2001; 103: 934-940.
197. HONG MK, MINTZ G, LEE CW, LEE BK, YANG TH, KIM YK, ET AL: The site of plaque rupture in natives coronary arteries. A three- vessel intra-vascular ultrasound analysis. J Am Coll Cardiol 2005; 46: 261-265.
198. HOFFMAN SN, TENBROOK JA, WOLF MP, PAUKER SG, SALEM DN, WONG JB: A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight - year outcomes. J Am Coll Cardiol 2003; 41: 1293-1304.
199. STABLES RH: Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease [the Stent or Surgery trial]: a randomized controlled trial. Lancet 2002; 360: 695-670.
200. RODRÍGUEZ A, BERNARDI V, NAVIA J, BALDI J, GRINFELD L, MARTÍNEZ J, ET AL: Argentine randomized study: coronary Angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease [ERACI-II]: 30-day and one- year follow up results. ERACI-II Investigators. J Am Coll Cardiol 2001; 37: 51-58.
201. SERRUYS PW, ONG ATL, HERWERDEN LA, SOUSA E, JATENE A, BONNIER JJRM, ET AL: Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. The final analysis of the arterial revascularization therapies study [ARTS] randomized trial. J Am Coll Cardiol 2005; 46: 571-575.
202. CANNON CP, BRAUNWALD E, MCCABE CH, RADER DJ, ROULEAU JL, BELDER R, ET AL: Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
203. NAGHAVI M, LIBBY P, FALK E, CASSCELLS SW, LITOVSKY S, RUMBERG J, ET AL: From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108: 1772-1778.
204. LIBBY P: Act local, act global. Inflammation and the multiplicity of "vulnerable" coronary plaques. J Am Coll Cardiol 2005; 45: 1600-1602.
205. TEMPANY CM, MCNEIL BJ: Advances in biomedical imaging. JAMA 2001; 285: 562-567.
206. KAUL S, ITO H: Mycrovasculature in acute myocardial ischemia: Part I. Evolving concepts in pathophysiology, diagnosis and treatment. Circulation 2004; 109: 146-149.
207. KAUL S, ITO H: Mycrovasculature in acute myocardial ischemia: Part II. Evolving concepts in pathophysiology, diagnosis and treatment. Circulation 2004; 109: 310-315.
208. PORTER T, LI S, OSTER R, DELIGONUL U: The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing micro bubbles following restoration of thrombolysis in myocardial infarction [TIMI] 3 flow in patients with acute myocardial infarction. Am J Cardiol 1998; 82: 1173-1177.
209. SWINBURN JMA, LAHIRI A, SENIOR R: Intravenous myocardial contrast echocardiography predicts recovery of function early after acute myocardial infarction. J Am Coll Cardiol 2001; 38: 19-25.
210. GARCÍA-MOLL X, KASKI JC: Cardiopatía isquémica: marcadores de inflamación y riesgo cardiovascular. Rev Esp Cardiol 1999; 52: 990-1003.
211. GABAY C, KUSHNER I: Acute phase proteins and other systemic responses to inflammation .N Engl J Med 1999; 340: 448-454.
212. BERLINER JA, NAVAB M, FOGELMAN AM: Atherosclerosis: basis mechanism-oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-96.
213. NAVARRO-LÓPEZ F. Bases genéticas de la enfermedad coronaria. Rev Esp Cardiol 2002; 55: 413-31.
214. YAMADA Y, IZAWA H, ICHIHARA S: Prediction of the risk of myocardial infarction from polymorphism in candidate genes. N Engl J Med 2002; 347: 1916-23.
215. HANSSON GK, LIBBY P, SCHONBECK U, YAN ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281-291.
216. HANSSON GK: Immune mechanism in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 1876-1890.
217. BINDER CJ, CHANG MK, SHAW PX, MILLER YI, HARTVIGSEN K, DEWAN A, WITZUM: Innate and acquired immunity in atherogenesis. Nat Med 2002; 8: 1218-1226.
218. LUPI HE, GONZÁLEZ PH, JUÁREZ UH, CHUQUIURE E, VIEYRA G, MARTINEZ SC: La meta de la reperfusión en los síndromes isquémicos coronarios agudos con elevación del segmento ST. "Lo que hay más allá del flujo TIMI 3 epicárdico". Arch Cardiol Mex 2002; 72: 311-349.